Background: K1 capsular polysaccharide is usually expressed in uropathogenic E. coli.The aim of current study was to evaluate the effect of BipA in the regulation of K1 capsular polysaccharide expression in E. coli. Methods: In order to identify the role of BipA in theK1 capsule expression,bipA gene was deletedin the UPEC strain UTI89.Results: The flow cytometry analyses showed that the capsular polysaccharide expressedon the UTI89ΔbipA cells was less thanthe capsular polysaccharide present on the wild type UTI89 cells. Also, plaque assays using K1specific bacteriophage showed that the plaque diameter produced on UTI89ΔbipA was about 1/2 the plaque diameter produced on wild typeUTI89indicated a reduction in the capsular polysaccharide expression from UTI89ΔbipA in comparison with UTI89.Conclusion: These results showed that the expression of K1 capsular polysaccharide is upregulated by BipA.
Introduction
Most of the urinary tractinfections (UTIs) are caused by Uropathogenic Escherichia coli (UPEC) [1] . UPEC strains have both structural and secreted virulence factors that are required to cause disease [2, 3] . During infection, UPEC colonize the bladder and cause cystitis. Also, it can move through the ureters and cause pyelonephritis in the kidneys. The host responses aretriggered due to UPEC infection leading to production of cytokine, neutrophil influx and exfoliation of the infected bladderepithelial cells [4, 5] .
A number of strategieshave been evolved by UPEC to avoid the host innate immune responses, allowing the bacteria to colonize the urinary tract effectively [6] . Once inside host cells, UPEC rapidlymultipliesforming large colonies known as intracellular bacterial communities (IBCs). These IBCsthen emerge by bacteria to infect and colonize newcells [7] .The capsular polysaccharide (K antigen) on bacterial cell surface is the key virulence factor associated withUPEC.The capsule protects bacteria from harmful effects of desiccation [8] , and has been shown to be vital in bacterial adhesion to host cells [9] . The presence of capsular polysaccharide gives an advantage over the host nonspecific defense mechanisms such as phagocytosis and complement-mediated killing [10] .
There are fourgroups(1-4) of E. coli polysaccharide capsules which are classified according to genetic and biochemical criteria [11, 12] . The expression of capsular polysaccharide of group 2 (K1 capsules) is linked with the E. coliinvasive isolates including UPEC. This expression is temperature-dependent that capsular polysaccharidebeing expressed only at37ºC [13] .Group 2 E. colicapsule gene cluster hasa conserved genetic organizationwhich is composed of threeregions ( Figure 1 ). Regions 1 and 3 encode proteins (Kps) associated with the polysaccharide exportation across the inner membrane, periplasm and outer membrane. Flanked by regions 1 and 3, region 2 genesis involved in the biosynthesis of a particular polysaccharide. Regulation of Group 2 capsule gene clusteroccurs principally at the level of transcription.Several global regulators (SlyA, HNS, RfaH, andIHF) are involved in this regulation by acting attwo convergent temperature-regulated promoters [14, 15, 16, 17, 18] . [19] .(Regions 1 and 3 (kps FEDUCS) and (kps MT, respectively)are conserved throughout Group 2 capsular polysaccharides while Region 2 is serotype-specific. PR1 and PR3 are major convergent promoters that control transcription of the genes).
Figure (1) Genetic organization of the K1 capsule gene cluster
Despite the growing understanding of the group 2 capsular polysaccharide regulation, more research is needed to understand the role of known and putative regulatory proteins in this regulation. BipAis a ribosome-binding protein which regulates gene expression atthe translation level [20] . Also, it is involvedin the regulation ofa variety of cellular processes such as symbiosis,bacterial virulence, resistance to host defenses, swarming motility andbiofilm [21] .
The aim of current study was to evaluate the effect of BipA in the regulation of K1 capsular polysaccharide expression in E. coli.
Materials and Methods

Bacterial strains, plasmids and growth conditions
The strains and plasmids used during this study werelisted in Table (1 
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grown overnight in LB then diluted 1:100 into fresh media and grown with shaking at 200rpm at 37°C, and the desired growth phase was determined by optical density at a wavelength of 600nm (OD 600 nm).
Table (1) Strains, plasmids and primers used and generated in this study
Strain
Genotype [22] UTI89 K1+, cystitis-derived isolate of serotype O18:K1:H7 [23] UTI89∆bipA bipAgene deletion mutant of UTI89 This study
Multi-copy vector, muti-cloning site inside lacZgene, Amp r Stratagene pCoC2 gfp TCD FRT-Kan r -FRT [24] pDOC-C Sce1-Kan r -Sce1 sacBAmp r [25] pACBSCE I-Sce1, λ-Red, Cm r [25] pKSB pBluescript KS+ carrying bipA gene This study Primer
Polymerase chain reaction (PCR)
Standard PCR was performed using Hybaid thermal cycler. Each reaction of 50μl contained5μl 10x PCR buffer (Roche Molecular Biochemicals),5μlof forward and reverse primers each ( 
Construction of bipA gene deletion strain UTI89∆bipA
The gene doctoring method of [25] was used to delete bipA gene in UTI89 strain by homologous recombination.
Briefly, the forward and reverse primers bipA-F and bipA-R containing the flanks of bipA gene were used to amplify the Kan cassette from pCoC2plasmid. The PCR product was digested with BamHI and SalI and cloned into the cloning region of pDOC-C plasmid which was verified by PCR and DNA sequencing using DCS1 and DCS2
primers. The resulting plasmid and Pacbsce plasmid were transformed into UTI89. After induction of recombination as described by [25] , the resulting UTI89∆bipAstrain wasconfirmed by PCR and sequencingusing bipA2-F and bipA2-R primers. 
K1-specific bacteriophage assay
Complementation of the bipA mutation
In order to obtain the complementation plasmid, bipAC-F and bipAC-R primers were used to amplify theDNA fragment containing the promoter region and coding sequence of bipA gene. The PCR product was digested with EcoRIand BamHI and cloned into cloning region of pKS+ plasmid to generate the complementation plasmid pKSB which was verified by PCR and DNA sequencing using M13-F and M13-R primers.
Flow cytometry assay
Overnight bacterial cultures were diluted 1:100 into fresh LB broth and grown to the required ODat 37°C with shaking.Around 10 8 cells were washed three times in PBS and resuspended inPBS/ 1% BSA and incubated on rotary 
Results and discussion
bipA gene deletion in UTI89 strain (UTI89∆bipA)
To determine the effect of bipA mutation on the regulation of K1 capsular polysaccharide production, UTI89ΔbipA strain was generated by deleting the bipA gene using the gene doctoring method of [25] ( thebipA mutant in which the gene doctoring method of [25] was used. (B)Lane 1 represents the UTI89ΔbipAfragment 
BipA positively regulates the production of K1 capsules
To identify theeffect of BipA on K1capsule expression, flow cytometry analyses of UTI89ΔbipAand UTI89were performed. The results in Figure ( 3) showed that the capsular polysaccharide expressedon the UTI89ΔbipA cells was less thanthe capsular polysaccharide present on the wild type UTI89 cells (less fluorescence intensity), which indicatedlower expressionof K1 capsule from UTI89ΔbipA. These results agreed with [13] who showed that the bipA mutation negatively regulated the K5 capsule production. UTI89ΔbipA. Bacteria were grown to the required OD (OD 600 = 1.0) at 37°C. The y-axis represents cells number andthe x-axis represents fluorescence intensity. The experiment was carried out three times.
In order to further investigate the effect of BipAinthe regulationof capsule production,plaque assays were performed using K1-specific bacteriophage on UTI89ΔbipAand the wild type UTI89. The results showed that the plaque diameter produced on UTI89ΔbipA was about 1/2 of the plaque diameter produced on wild typeUTI89 (Figure 4) .
These results suggested a reduction in the capsular polysaccharide expression from UTI89ΔbipAin comparison with UTI89. Therefore,the results of flow cytometry analysesand the plaque assaysreferred to a reduction in capsule production from UTI89ΔbipAand this indicateda positive role of BipA in capsule production. (pKSB). Bacteria were grown to late exponential phase (OD 600 = 1.0)at 37°C then treated with K1-specific bacteriophage. The experiment was carried out three times.
pKSB complements the bipA mutation
Plasmidp KSB and its parent vector KS+ were transformed into UTI89ΔbipA in order to complement the bipAmutation and assayed for plaques using K1-specific bacteriophage. The results in Figure (4) showed that plasmid pKSBwas able to complement the loss of bipA and restore the plaque diameter to a level similar to the plaque diameter of wild type UTI89 indicating an increase in capsule expression. The empty vector pKS+ did not show any effect on the plaque diameter of the bipA mutant. These results indicated that BipA activates K1 capsule production.
Conclusion
The results in this paper demonstrated that the expression of K1 capsular polysaccharide is up-regulated by BipA.
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